499 The impact of sustained virological response (SVR) on health-related quality of life (HRQL) in patients with chronic hepatitis C (CHC) and persistently normal ALT levels (PNALT) treated with peginterferon alfa-2A (PEGASYS®) and ribavirin (COPEGUS®)
- 31 December 2004
- journal article
- abstracts
- Published by Elsevier BV in Journal of Hepatology
- Vol. 40, 147
- https://doi.org/10.1016/s0168-8278(04)90499-0